In principle, the COVID-19 outbreak could provide a compelling new justification for expediting the processing of certain Freedom of Information Act requests related to the pandemic. But it is more likely to slow down the handling of most requests as agency employees work remotely and other concerns are understandably prioritized.
The impact of COVID-19 was surveyed by the Congressional Research Service in Freedom of Information Act (FOIA) Processing Changes Due to COVID-19: In Brief, March 27, 2020.
Other noteworthy new and updated reports from CRS include:
U.S. Role in the World: Background and Issues for Congress, updated March 27, 2020
The Employment-Based Immigration Backlog, March 26, 2020
Demographic and Social Characteristics of Persons in Poverty: 2018, March 26, 2020
Occupational Safety and Health Administration (OSHA): Emergency Temporary Standards (ETS) and COVID-19, March 26, 2020
Arms Control and Nonproliferation: A Catalog of Treaties and Agreements, updated March 26, 2020
Congressional Use of Advisory Commissions Following Crises, CRS In Focus, March 25, 2020
These recommendations can catapult the Advisory Committee structure into one that continues providing the government with the best advice.
Without the permitting workforce needed for implementation, the American public will not reap the benefits of rural broadband access, resilient supply chains, and clean, accessible water.
Improving public awareness of FDA Advisory Committees would improve public trust and deter misinformation related to the approval of medical products.
FAS has been a leading voice for action on this topic, and has developed a compendium of 150+ heat-related federal policy recommendations.